Dn B Asset Management As Regenxbio Inc. Transaction History
Dn B Asset Management As
- $25.3 Billion
- Q3 2025
A detailed history of Dn B Asset Management As transactions in Regenxbio Inc. stock. As of the latest transaction made, Dn B Asset Management As holds 17,923 shares of RGNX stock, worth $206,293. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,923
Previous 18,491
3.07%
Holding current value
$206,293
Previous $132,000
30.3%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RGNX
# of Institutions
184Shares Held
43.6MCall Options Held
121KPut Options Held
99.6K-
Black Rock Inc. New York, NY8.61MShares$99.1 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.69MShares$54 Million4.99% of portfolio
-
Jpmorgan Chase & CO New York, NY4.04MShares$46.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.34MShares$38.4 Million0.0% of portfolio
-
State Street Corp Boston, MA1.98MShares$22.8 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $498M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...